degree from the University of Michigan Medical School, Ann Arbor, where he also completed a family practice residency. He also publishes a bimonthly e-mail dermatology quiz....17. Misko ML, Terracina JR, Diven DG. The frequency of erythromycin-resistant Staphylococcus aureus in impetiginized dermatoses. Pediatr Dermatol. 1995;12:12–5.18. Edlich RF, Horowitz JH, Nichter LS, Silloway KA, Morgan RF. Clinical syndromes caused by staphylococcal epidermolytic toxin. Compr Ther. 1985;11:45–8. 19. McLinn S. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo. J Am Acad Dermatol. 1990;22(5 pt 1):883–5. 23. Raz R, Miron D, Colodner R, Staler Z, Samara Z, Keness Y. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med. 1996;156:1109–12.This article is one in a series coordinated by Daniel L. Sulberg, M.D., director of dermatology curriculum at the Utah Valley Family Practice Residency, Provo, Utah.This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions.